JP2018514592A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514592A5
JP2018514592A5 JP2018508628A JP2018508628A JP2018514592A5 JP 2018514592 A5 JP2018514592 A5 JP 2018514592A5 JP 2018508628 A JP2018508628 A JP 2018508628A JP 2018508628 A JP2018508628 A JP 2018508628A JP 2018514592 A5 JP2018514592 A5 JP 2018514592A5
Authority
JP
Japan
Prior art keywords
dry eye
composition
subject
pharmaceutically acceptable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018508628A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018514592A (ja
JP7245649B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/030142 external-priority patent/WO2016179007A1/en
Publication of JP2018514592A publication Critical patent/JP2018514592A/ja
Publication of JP2018514592A5 publication Critical patent/JP2018514592A5/ja
Application granted granted Critical
Publication of JP7245649B2 publication Critical patent/JP7245649B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018508628A 2015-05-01 2016-04-29 眼疾患を治療するためのアディポネクチンペプチド模倣薬(関連出願の相互参照) Active JP7245649B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562156127P 2015-05-01 2015-05-01
US62/156,127 2015-05-01
PCT/US2016/030142 WO2016179007A1 (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders

Publications (3)

Publication Number Publication Date
JP2018514592A JP2018514592A (ja) 2018-06-07
JP2018514592A5 true JP2018514592A5 (cg-RX-API-DMAC7.html) 2022-10-27
JP7245649B2 JP7245649B2 (ja) 2023-03-24

Family

ID=57218292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018508628A Active JP7245649B2 (ja) 2015-05-01 2016-04-29 眼疾患を治療するためのアディポネクチンペプチド模倣薬(関連出願の相互参照)

Country Status (12)

Country Link
US (6) US10987401B2 (cg-RX-API-DMAC7.html)
EP (3) EP4014985A1 (cg-RX-API-DMAC7.html)
JP (1) JP7245649B2 (cg-RX-API-DMAC7.html)
KR (2) KR20170141692A (cg-RX-API-DMAC7.html)
CN (3) CN107530396B (cg-RX-API-DMAC7.html)
AU (3) AU2016257724B2 (cg-RX-API-DMAC7.html)
CA (3) CA2981822C (cg-RX-API-DMAC7.html)
DK (1) DK3288577T3 (cg-RX-API-DMAC7.html)
ES (1) ES2903448T3 (cg-RX-API-DMAC7.html)
IL (1) IL272449A (cg-RX-API-DMAC7.html)
SG (1) SG11202001140UA (cg-RX-API-DMAC7.html)
WO (2) WO2016179007A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2903448T3 (es) * 2015-05-01 2022-04-01 Allysta Pharmaceuticals Inc Peptidomiméticos de adiponectina para el tratamiento de trastornos oculares
WO2018165218A1 (en) * 2017-03-09 2018-09-13 Allysta Pharmaceuticals, Inc Peptides for dry eye disease
CN107149676A (zh) * 2017-05-05 2017-09-12 杨硕 脂联素和脂联素/胰岛素混合液在改善及治疗眼表角膜上皮及神经损伤中的应用
WO2019061491A1 (en) * 2017-09-30 2019-04-04 Pro Sunfun Biotech Research And Development Co., Ltd. PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF
CN109912685B (zh) * 2017-12-13 2022-05-06 三凡生技研发股份有限公司 眼睛保护胜肽及其组合物及使用该胜肽的用途
US20190292223A1 (en) * 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetics for treatment of eye disease
CN113164551A (zh) * 2018-10-24 2021-07-23 雅利斯塔制药公司 脂联素肽模拟物制剂
JP7699426B2 (ja) * 2018-11-30 2025-06-27 ロート製薬株式会社 光線による障害からの細胞保護用眼科組成物
BR112022002467A2 (pt) 2019-09-18 2022-07-19 Alcon Inc Insertos oculares de hidrogel suave embalados a úmido
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
US11213551B1 (en) 2021-04-05 2022-01-04 Korb Research, Llc. Ocular treatment compositions and methods of use thereof
WO2023069549A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023069255A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023107796A1 (en) * 2021-12-11 2023-06-15 The Regents Of The University Of California Ophthalmic formulations for macular degeneration
WO2024180472A1 (en) 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
KR102609115B1 (ko) * 2023-06-08 2023-12-05 주식회사 엔큐라젠 펩타이드를 포함하는 안구 질환의 치료용 조성물
WO2026032238A1 (en) * 2024-08-06 2026-02-12 The Chinese University Of Hong Kong Compositions and methods for treating tendon and ligament injuries utilizing biomaterials and adiponectin or its mimics
WO2026049532A1 (ko) * 2024-08-30 2026-03-05 서울과학기술대학교 산학협력단 알레르기성 결막염 치료를 위한 약학적 제제가 담지된 콘택트렌즈 및 이의 제작 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE4437604A1 (de) 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
DE69936409T2 (de) 1998-04-28 2008-04-17 Laboratoires Serono S.A., Coinsins Verfahren zur schrittweise Bindung von Polyethylenglykol (PEG) an Polypeptide
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
JP2005535561A (ja) * 2002-01-18 2005-11-24 プロテミックス コーポレイション リミティド アディポネクチンのグリコアイソフォームとその使用
AU2006242651B2 (en) * 2005-04-29 2013-05-16 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
WO2012142142A2 (en) 2011-04-12 2012-10-18 Temple University - Of The Commonwealth System Higher Education Adiponectin receptor agonists and methods of use
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
WO2014066775A1 (en) * 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
ES2903448T3 (es) * 2015-05-01 2022-04-01 Allysta Pharmaceuticals Inc Peptidomiméticos de adiponectina para el tratamiento de trastornos oculares

Similar Documents

Publication Publication Date Title
JP5583310B2 (ja) 眼球の症状の予防及び治療のための眼科用製剤
CA2806942C (en) Compounds for the treatment/prevention of ocular inflammatory diseases
US20070265353A1 (en) Eye Drops for the Treatment of Dry Eye
KR20120104980A (ko) 각막 및 결막의 병변을 치료하기 위한 프로스타글란딘 f2알파 및 유사체의 용도
US20230348534A1 (en) Sap and peptidomimetics for treatment of eye disease
CA2909806C (en) Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
CN111032070A (zh) 用于治疗眼病的脂联素拟肽
JP2024079810A (ja) キレート剤、浸透促進剤およびヒドロキシエチルセルロースを含む眼科疾患治療用製剤
CN116367829A (zh) 用于干眼的预防剂、改善剂和治疗剂
AU2006260184B2 (en) Prophylactic or therapeutic agent for corneal/conjunctival disease
AU2011282679A1 (en) Preservative free bimatoprost solutions
JP5605072B2 (ja) 角結膜疾患の予防又は治療剤
JP4249185B2 (ja) 涙液異常の治療のための眼科用組成物
RU2679319C1 (ru) Гелеобразная искусственная слеза с антисептическим и репаративным действием
RU2847424C1 (ru) Контактная линза для доставки лекарственного средства
JP4778515B2 (ja) 角膜疾患治療剤
JP2002205944A (ja) ファルネシル酢酸を有効成分とする角結膜疾患治療剤
WO2002038149A1 (en) Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
Al-Mugheiry et al. Once-daily Preservative-free Topical Anti-glaucomatous Monotherapy–A Better Approach?
WO2023160499A1 (zh) 一种肽、含有所述肽的眼用药物组合物及其用途
US20210052582A1 (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor
JP2005200411A (ja) 涙液層安定化剤
JP2007063218A (ja) 角膜疾患治療剤
WO2005058932A1 (ja) 涙液層安定化剤